Abstract:Naturally occurring pentacyclic triterpenes, such as betulinic acid (BA) and its derivatives, exhibit various pharmaceutical activities and have been the subject of great interest, in particular for their antiviral properties. Here, we found a new anti-influenza virus conjugate, hexakis 6-deoxy-6-[4-N-(3β-hydroxy-lup-20(29)-en-28-oate)aminomethyl-1H-1,2,3-triazol-1-yl]-2,3-di-O-acetyl-α-cyclodextrin (CYY1-11, 1), in a mini library of pentacyclic triterpene–cyclodextrin conjugates by performing a cell-based screening assay and then exploring the underlying mechanisms. Our results showed that conjugate 1 possessed a high-level activity against the influenza virus A/WSN/33 with an IC50 value of 5.20 μM (SI > 38.4). The study of the mechanism of action indicated that conjugate 1 inhibited viral replication by directly targeting the influenza hemagglutinin protein (KD = 1.50 μM), thus efficiently preventing the attachment of the virion to its receptors on host cells and subsequent infection. This study suggests that multivalent BA derivatives have possible use as a new class of influenza virus entry inhibitors.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.molpharmaceut.0c00244?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.0c00244</a>.Effects of conjugate 1 on later viral life cycle processes after the attachment of influenza virus; interaction of BA with influenza HA protein; synthesis process of the two building blocks: hexakis 6-deoxy-6-azide-2,3-di-O-acetyl-α-CD 4 and N-propargyl-3β-hydroxy-lup-20(29)-en-28-amide 7; and 1H NMR, 13C NMR, DPET135, 1H–13C HSQC, and MALDI-TOF MS of conjugate 1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.molpharmaceut.0c00244/suppl_file/mp0c00244_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles

Preparation of Eicosavalent Triazolylsialoside-Conjugated Human Serum Albumin As a Dual Hemagglutinin/neuraminidase Inhibitor and Virion Adsorbent for the Prevention of Influenza Infection

Multivalent S-sialoside Protein Conjugates Block Influenza Hemagglutinin and Neuraminidase.

Multivalent Neuraminidase Hydrolysis Resistant Triazole-Sialoside Protein Conjugates As Influenza-Adsorbents

Multivalent Interactions Between Fully Glycosylated Influenza Virus Hemagglutinins Mediated by Glycans at Distinct N-glycosylation Sites

Synthesis and In Vitro Anti-Influenza Virus Evaluation of Novel Sialic Acid (C-5 and C-9)-Pentacyclic Triterpene Derivatives

Amide-sialoside Protein Conjugates As Neomucin Bioshields Prevent Influenza Virus Infection.

Synthesis of a Hexavalent Betulinic Acid Derivative as a Hemagglutinin-Targeted Influenza Virus Entry Inhibitor

Design, Synthesis And Biological Activity Evaluation Of Novel Conjugated Sialic Acid And Pentacyclic Triterpene Derivatives As Anti-Influenza Entry Inhibitors

Glycopolymer with Sulfated Fucose and 6'-Sialyllactose as a Dual-Targeted Inhibitor on Resistant Influenza A Virus Strains

Potent sialic acid inhibitors that target influenza A virus hemagglutinin

A Zanamivir-protein conjugate mimicking mucin for trapping influenza virion particles and inhibiting neuraminidase activity

Nine-valent oleanolic acid conjugates as potent inhibitors blocking the entry of influenza A virus

Pentacyclic triterpenes grafted on CD cores to interfere with influenza virus entry: A dramatic multivalent effect.

Guanidinothiosialoside-Human Serum Albumin Conjugate Mimics mucin Barrier to Restrict Influenza Infection

Thiosialoside-decorated polymers use a two-step mechanism to inhibit both early and late stages of influenza virus infection

Inhibition of influenza virus infection by multivalent pentacyclic triterpene-functionalized per-O-methylated cyclodextrin conjugates.

Synthesis of multivalent sialyllactose-conjugated PAMAM dendrimers: Binding to SARS-CoV-2 spike protein and influenza hemagglutinin

Design, Synthesis and Biological Evaluation of Amino Acids-Oleanolic Acid Conjugates As Influenza Virus Inhibitors.

Synthesis of Novel Pentacyclic Triterpene-Neu5ac2en Derivatives and Investigation of Their in Vitro Anti-Influenza Entry Activity.

Sialylated Immunoglobulin G Can Neutralize Influenza Virus Infection Through Receptor Mimicry